| mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
-0.19 |
6e-09 |
| mRNA |
AC220 |
GDSC1000 |
pan-cancer |
AAC |
-0.19 |
7e-08 |
| mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
3e-07 |
| mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
5e-07 |
| mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
3e-06 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
| mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
3e-05 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
3e-05 |
| mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
4e-05 |